{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:21:53Z","timestamp":1782760913137,"version":"3.54.5"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/gco.0000000000000068","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T10:10:29Z","timestamp":1397038229000},"page":"162-167","source":"Crossref","is-referenced-by-count":12,"title":["Recent progress in the utility of anti-M\u00fcllerian hormone in female infertility"],"prefix":"10.1097","volume":"26","author":[{"given":"Anna G.-A.","family":"Grynnerup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Lindhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","first-page":"271","article-title":"Reserchessur la differenciation de lembryon de lapin.","volume":"36","author":"Jost","year":"1947","journal-title":"Arch Anat Microsc Morphol Exp"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0022-3468(81)80827-5","article-title":"The ontogeny of Mullerian inhibiting substance in the gonads of the chicken.","volume":"16","author":"Hutson","year":"1981","journal-title":"J Pediatr Surg"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1600-0412.2012.01471.x","article-title":"The role of anti-Mullerian hormone in female fertility and infertility - an overview.","volume":"91","author":"Grynnerup","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number.","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil Steril"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum antimullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.fertnstert.2013.03.001","article-title":"Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimullerian hormone.","volume":"99","author":"Toner","year":"2013","journal-title":"Fertil Steril"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach.","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","article-title":"Determining an antimullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve.","volume":"30","author":"Merhi","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.rbmo.2013.09.017","article-title":"Probability of live birth in women with extremely low AMH concentrations.","volume":"28","author":"Lukaszuk","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.rbmo.2013.07.008","article-title":"Anti-Mullerian hormone versus antral follicle count for defining the starting dose of FSH.","volume":"27","author":"Lan","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts.","volume":"25","author":"Van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humrep\/det413","article-title":"Anti-Mullerian hormone: reality check.","volume":"29","author":"Clark","year":"2014","journal-title":"Hum Reprod"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10815-012-9880-1","article-title":"Correlation between three assay systems for anti-Mullerian hormone (AMH) determination.","volume":"29","author":"Li","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/des260","article-title":"Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.","volume":"27","author":"Rustamov","year":"2012","journal-title":"Hum Reprod"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2012-3995","article-title":"Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study.","volume":"98","author":"Dolleman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.rbmo.2010.06.041","article-title":"The association between anti-Mullerian hormone and IVF pregnancy outcomes is influenced by age.","volume":"21","author":"Wang","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"e61095","DOI":"10.1371\/journal.pone.0061095","article-title":"Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.fertnstert.2013.01.132","article-title":"Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response.","volume":"99","author":"Hadlow","year":"2013","journal-title":"Fertil Steril"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.fertnstert.2013.04.010","article-title":"Whatever its variability, antimullerian hormone remains the most stable hormonal predictor.","volume":"100","author":"La Marca","year":"2013","journal-title":"Fertil Steril"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/AOG.0b013e3182116bc8","article-title":"Antimullerian hormone as a predictor of natural fecundability in women aged 30-42 years.","volume":"117","author":"Steiner","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R26-7-20210129","first-page":"857","article-title":"Can anti-Mullerian hormone be predictive of spontaneous onset of pregnancy in women with unexplained infertility J Obstet G","volume":"33","author":"Casadei","year":"2013","journal-title":"ynaecol"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Antimullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.","volume":"96","author":"Broer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2011-3032","article-title":"Antimullerian hormone as a predictor of time to menopause in late reproductive age women.","volume":"97","author":"Freeman","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1210\/jc.2012-4228","article-title":"The relationship between anti-Mullerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.","volume":"98","author":"Dolleman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"e57005","DOI":"10.1371\/journal.pone.0057005","article-title":"Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status.","volume":"8","author":"La Marca","year":"2013","journal-title":"PLoS One"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2012-3176","article-title":"Modeling age at menopause using serum concentration of antimullerian hormone.","volume":"98","author":"Tehrani","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrendo.2011.224","article-title":"Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency.","volume":"8","author":"Visser","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.fertnstert.2012.09.039","article-title":"Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy.","volume":"99","author":"Dillon","year":"2013","journal-title":"Fertil Steril"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.fertnstert.2013.08.052","article-title":"Antimullerian hormone as a measure of reproductive function in female childhood cancer survivors.","volume":"101","author":"Lunsford","year":"2014","journal-title":"Fertil Steril"},{"key":"R35-7-20210129","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1210\/jc.2011-3180","article-title":"Anti-Mullerian hormone is a marker of gonadotoxicity in pre and postpubertal girls treated for cancer: a prospective study.","volume":"97","author":"Brougham","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","article-title":"Pretreatment anti-Mullerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.","volume":"49","author":"Anderson","year":"2013","journal-title":"Eur J Cancer"},{"key":"R37-7-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pbc.23363","article-title":"Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study.","volume":"59","author":"Hamre","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.rbmo.2013.04.016","article-title":"Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve.","volume":"27","author":"Urman","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"R39-7-20210129","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/jc.2012-1558","article-title":"The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis.","volume":"97","author":"Raffi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.fertnstert.2012.08.009","article-title":"Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications.","volume":"98","author":"Somigliana","year":"2012","journal-title":"Fertil Steril"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/aogs.12234","article-title":"Anti-Mullerian hormone levels in salpingectomized compared with nonsalpingectomized women with tubal factor infertility and women with unexplained infertility.","volume":"92","author":"Grynnerup","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R42-7-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/09513590.2012.743004","article-title":"Influence of various tubal surgeries to serum antimullerian hormone level and outcome of the subsequent IVF-ET treatment.","volume":"29","author":"Ni","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R43-7-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/09513590.2013.864273","article-title":"Anti-Mullerian hormone levels in women with polycystic ovarian syndrome compared with normal women of reproductive age in China.","volume":"30","author":"Tian","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"R44-7-20210129","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome A systematic review and meta-analysis of extracted data.","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-7-20210129","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-Mullerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R46-7-20210129","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.fertnstert.2013.06.030","article-title":"Serum antimullerian hormone in response to dietary management andor physical exercise in overweightobese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.","volume":"100","author":"Nybacka","year":"2013","journal-title":"Fertil Steril"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0000000000000068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:41:56Z","timestamp":1620952916000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201406000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0000000000000068","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}